You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY23 is not expected to be complete until September, 2024.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

Displaying 201851 - 201860 of 205043 results
  1. A New Tool Kit for Whole-Genome Mapping and Complementation in Drosophila

    SBC: GENETIVISION CORPORATION            Topic: NIGMS

    DESCRIPTION (provided by applicant): The ultimate goal of this proposal is to generate, maintain, and distribute a new collection of duplication stocks that covers nearly the entire euchromatic autosomal portion of the Drosophila melanogaster genome. Sincethis collection will represent a powerful new set of tools that will benefit virtually all Drosophila geneticists, t is likely that there will b ...

    SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health
  2. Development of an Atmospheric Plasma Applicator to Treat Chronic Wounds

    SBC: ADVANCED PLASMA PRODUCTS, INC.            Topic: NIGMS

    DESCRIPTION (provided by applicant): Annually, 5 to 7 million Americans are treated for chronic wounds that arise from diabetes, lower extremity arterial disease, lower extremity venous disease, pressure ulcers, and traumatic injuries, including burns, demonstrating the need for new advanced technologies for treatment. Advanced Plasma Products will build upon its successful Phase I results and adv ...

    SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health
  3. Smart Polymer Reagents for Sensitivity and Speed-enhanced Clinical Diagnostics

    SBC: NEXGENIA, INC.            Topic: NIGMS

    DESCRIPTION (provided by applicant): Magnetic beads have gained increasing use as a convenient separation technique for many forms of cell, nucleic acid and protein isolations and analyses. In particular, the manufacturers of clinical immunoassays utilizemagnetic beads both as a solid support for antibodies specifically targeted to analytes of clinical importance, and as the separation means to is ...

    SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health
  4. Mesodissection Device Phase II

    SBC: AVANSCI BIO, LLC            Topic: NIGMS

    DESCRIPTION (provided by applicant): Microscopic analysis of tissue mounted on glass slides is commonly used to study cancer, non-neoplastic entities such as heart disease and diabetes, and normal cell function. Researchers utilize micro and macro tissue dissection techniques in order to recover specific areas of these tissue sections from the slides for subsequent molecular analysis including rea ...

    SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health
  5. Next-Generation Clinical Mass Spectrometry Platform

    SBC: VIRGIN INSTRUMENTS CORPORATION            Topic: NIGMS

    DESCRIPTION (provided by applicant): Mass spectrometry is now established as an essential tool in the biological research laboratory and is widely used for characterizing clinicaly significant peptides and proteins. However, more than twenty years after the advent of the enabling approaches of matrix-assisted laser desorption/ionization (MALDI) and electrospray ionization, there has been only marg ...

    SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health
  6. Studies of DNA Methyltransferases

    SBC: NEW ENGLAND BIOLABS, INC.            Topic: NIGMS

    DESCRIPTION (provided by applicant): This project takes advantage of a DNA sequencing technology newly developed by Pacific Biosciences called SMRT sequencing. In addition to providing the DNA base sequence, this approach also allows the detection of modified bases. DNA methyltransferases have traditionally been rather difficult to characterize and as a result, we do not currently know the accurat ...

    SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health
  7. A protease-deficient, low mutation rate E. coli for biotherapeutics production

    SBC: SCARAB GENOMICS, LLC            Topic: NIGMS

    DESCRIPTION (provided by applicant): Biotherapeutics is a fast-growth sector in the pharmaceutical market with monoclonal antibodies accounting for almost 50% of the 100 billion USD spent each year on protein therapies. Bacterial fermentation, which accounts for about 35% of all protein therapeutics manufacture, continues to be the most economical method of generating proteins that do not require ...

    SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health
  8. Sorted libraries of error-free long oligonucleotides

    SBC: BIODISCOVERY LLC            Topic: NIGMS

    DESCRIPTION: Synthetic Biology is full of promises ranging from discovery and production of new drugs, targeted therapies modifying organisms such as yeast or E. coli or creating totally new ones, higher crop yields, CO2 sequestration to bio-energy projects. However, these goals have been difficult to reach primarily due to the difficulty of De Novo gene synthesis and synthesis of new control and ...

    SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health
  9. Reshapable Hydrogel Tissue Expander

    SBC: AKINA, INC.            Topic: NIGMS

    DESCRIPTION (provided by applicant): For dental and other applications there is a great need for self-filling tissue expanders with the capacity to be reshaped to fit the void by the surgeon at time of implantation. Akina recently completed an initial Phase II study using its hydrogel-based reshapable swelling tissue expanders (Restiex(R)). The study validated the function of Restiex to generate a ...

    SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health
  10. Phase II Commercialization of Continuous Countercurrent Tangential Chromatography

    SBC: CHROMATAN INC            Topic: NIGMS

    DESCRIPTION: This SBIR Phase II proposal to NIH requests 985,000 funding for Chromatan, Inc. to scale up and commercialize Continuous Countercurrent Tangential Chromatography (CCTC) for the purification of high value biological products, e.g., monoclonalantibodies for the treatment of cancer and arthritis. Downstream processing currently accounts for as much as 80% of the overall cost of product ...

    SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government